Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | PDE4A | P27815 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL99322 | 0.97 | PTGS1 (0.38) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL7622762 | 0.97 | PTGS1 (0.38) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| Ammonia Solution, Strong SCHEMBL3903413 | 0.95 | PTGS1 (0.36) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| Hydrochloric Acid SCHEMBL1336339 | 0.95 | PTGS1 (0.36) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL9898850 | 0.95 | PTGS1 (0.36) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL9898366 | 0.95 | PTGS1 (0.36) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL29419676 | 0.95 | PTGS1 (0.36) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL11237951 | 0.89 | APP (0.39) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL22056603 | 0.89 | APP (0.34) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL18269185 | 0.87 | CA1 (0.34) | PTGS1PDE4ALMNASLC6A6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220226325-A1 | PHARMACEUTICAL COMPOSITION FOR TOPICAL WOUND TREATMENT | CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECN (AR) | 2022-07-21 | — | — | US | claimed |
| EP-4025562-A1 | PHARMACEUTICAL COMPOSITION FOR TOPICAL WOUND TREATMENT | Consejo Nacional de Investigaciones Científicas Y Técnicas (CONICET) (AR) | 2022-07-13 | — | — | EP | claimed |
| WO-2021046290-A1 | PHARMACEUTICAL COMPOSITION FOR TOPICAL WOUND TREATMENT | CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECNICAS (AR) | 2021-03-11 | — | — | WO | claimed |
| US-4563291-A | Method of preparation of substituted amino-alkyl sulfonic acid compounds and use in the treatment of subterranean formations | HALLIBURTON COMPANY (US) | 1986-01-07 | — | — | US | claimed |
| WO-2023141721-A1 | ANTICHOLINERGIC COMPOUNDS FOR USE IN TREATING NEUROMUSCULAR DISORDERS | UNIVERSITY OF MONTRÉAL (CA) | 2023-08-03 | — | — | WO | disclosed |
| WO-2023147489-A2 | ANTI-MUSK ANTIBODIES FOR USE IN TREATING NEUROMUSCULAR DISORDERS | argenx BV (BE) | 2023-08-03 | — | — | WO | disclosed |
| US-20220226325-A1 | PHARMACEUTICAL COMPOSITION FOR TOPICAL WOUND TREATMENT | CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECN (AR) | 2022-07-21 | — | — | US | disclosed |
| EP-4025562-A1 | PHARMACEUTICAL COMPOSITION FOR TOPICAL WOUND TREATMENT | Consejo Nacional de Investigaciones Científicas Y Técnicas (CONICET) (AR) | 2022-07-13 | — | — | EP | disclosed |
| US-11382913-B2 | Pharmaceutical composition for topical wound treatment | CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECNICAS (AR) | 2022-07-12 | — | — | US | disclosed |
| WO-2021046290-A1 | PHARMACEUTICAL COMPOSITION FOR TOPICAL WOUND TREATMENT | CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECNICAS (AR) | 2021-03-11 | — | — | WO | disclosed |
| US-9612204-B2 | Measurement of scale inhibitor in water systems | CONOCOPHILLIPS COMPANY (US) | 2017-04-04 | — | — | US | disclosed |
| US-20160349186-A1 | MEASUREMENT OF SCALE INHIBITOR IN WATER SYSTEMS | CONOCOPHILLIPS COMPANY | 2016-12-01 | — | — | US | disclosed |
| WO-2009085809-A1 | IONOMERS FOR IMPROVED COMPRESSION SET IN CERTAIN COPOLYMERS | THE POLYMER TECHNOLOGY GROUP INC. (US) | 2009-07-09 | — | — | WO | disclosed |
| US-20090087687-A1 | SULFONIC ACID POLYOL COMPOUND, POLYURETHANE RESIN, POLYURETHANE RESIN FOR MAGNETIC RECORDING MEDIUM, AND MAGNETIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
| US-20040241348-A1 | Recording paper, and image recording method and device using the same | FUJI XEROX CO., LTD. (JP) | 2004-12-02 | — | — | US | disclosed |
| EP-0406334-A4 | HYDROGEL DYE FILM SENSING ELEMENTS AND THEIR PREPARATION | — | 1991-11-13 | — | — | EP | disclosed |
| EP-0406334-A1 | HYDROGEL DYE FILM SENSING ELEMENTS AND THEIR PREPARATION | NELLCOR INCORPORATED (US) | 1991-01-09 | — | — | EP | disclosed |
| WO-1990000572-A1 | HYDROGEL DYE FILM SENSING ELEMENTS AND THEIR PREPARATION | NELLCOR INCORPORATED (US) | 1990-01-25 | — | — | WO | disclosed |
| EP-0169074-A2 | Treatment of subterranean formations | HALLIBURTON COMPANY (US) | 1986-01-22 | — | — | EP | disclosed |
| US-4563291-A | Method of preparation of substituted amino-alkyl sulfonic acid compounds and use in the treatment of subterranean formations | HALLIBURTON COMPANY (US) | 1986-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090087687-A1 | SULFONIC ACID POLYOL COMPOUND, POLYURETHANE RESIN, POLYURETHANE RESIN FOR MAGNETIC RECORDING MEDIUM, AND MAGNETIC RECORDING MEDIUM | ASH2L, ASIC1, HNRNPL | PTGS1 702/4885PDE4A 4801/4885LMNA 2778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.